Philip Colasante Pharmacies Pty Ltd and Australian Community Pharmacy Authority

Link copied
Case Copied 22 min read

Philip Colasante Pharmacies Pty Ltd and Australian Community Pharmacy Authority [2020] AATA 1529 (15 May 2020)

Division:GENERAL DIVISION

File Number:          2019/3674

Re:Philip Colasante Pharmacies Pty Ltd

Pharmec Pty Ltd

APPLICANTS

AndAustralian Community Pharmacy Authority

RESPONDENT

DECISION

Tribunal:Deputy President J W Constance

Date:15 May 2020

Place:Sydney

The decision under review, being the decision of the Australian Community Pharmacy Authority made 21 June 2019 to recommend that the application of Philip Colasante Pharmacies Pty Ltd and Pharmec Pty Ltd for approval to supply pharmaceutical benefits at particular premises not be approved, is affirmed.

.............................[sgd]...........................................

Deputy President J W Constance

CATCHWORDS

HEALTH - PHARMACISTS - application for approval to supply pharmaceutical benefits at premises other than premises in respect of which approval already granted - plan devised by Applicants based on National Health (Australian Community Pharmacy Authority Rules) Determination 2011 to relocate approval at expiration of two year period - National Health (Australian Community Pharmacy Authority Rules) Determination 2018 entered into force before expiration of two year period - whether Applicants can have benefit of previous Rules - whether exceptional circumstances exist - whether pharmaceutical benefits unable to be supplied at existing premises now and in the future - whether subsequent Rules offend common law presumption against retrospectivity - where subsequent Rules expressly designed to prevent establishment of temporary pharmacies which are subsequently relocated - where subsequent Rules have future effect on past events and speak only to future applications - amendment of Rules does not constitute exceptional circumstances within meaning of the Rules - inability to supply pharmaceutical benefits distinct from commercial viability of doing so - decision under review affirmed

LEGISLATION

National Health Act 1953 (Cth)

National Health (Australian Community Pharmacy Authority Rules) Determination 2018

CASES

Chang v Laidley Shire Council (2007) 234 CLR 1

Clare v Australian Community Pharmacy Authority [2015] FCA 653
Hopkins v Minister for Immigration, Citizenship, Migrant Services and Multicultural Affairs [2020] FCAFC 33

Plaintiff M174/2016 v Minister for Immigration and Border Protection (2018) 264 CLR 217

REASONS FOR DECISION

Deputy President J W Constance

15 May 2020

INTRODUCTION

  1. The approval of pharmacists to supply drugs under the Pharmaceutical Benefits Scheme is governed by the National Health Act 1953 (Cth) (the Act) and the National Health (Australian Community Pharmacy Authority Rules) Determination 2018 (the Rules).

  2. The Applicants are approved pharmacists under the scheme and provide pharmaceutical benefits in South Australia. As part of a “strategic plan” to develop their respective businesses, the Applicants applied to the Secretary of the Department of Health for approval to supply pharmaceutical benefits at proposed premises, being different to the interim premises in respect of which approval had previously been granted. As required by the Act, the Secretary referred their application to the Australian Community Pharmacy Authority.

  3. Having considered the application, the Authority concluded that the Applicants had not met the requirements of the Rules relating to the granting of approval. As a result, the Authority recommended to the Secretary that the application…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Philip Colasante Pharmacies Pty Ltd and Australian Community... and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2020] AATA 1529
Decision Date

CaseChat Overview and Summary

The Administrative Appeals Tribunal considered an application by Philip Colasante Pharmacies Pty Ltd and Pharmec Pty Ltd (the Applicants) to review a decision by the Australian Community Pharmacy Authority (the Authority). The dispute arose from the Applicants' plan to relocate a pharmaceutical benefits approval. Their strategy involved temporarily relocating an existing approval to interim premises for two years, obtaining a new approval at the original location, and then relocating the approval from the interim premises to a new, larger site after the two-year period. This plan was devised based on the understanding that the relevant rules permitted such relocations every two years.

The primary legal issues before the Tribunal were whether the Applicants could benefit from the previous rules governing relocation periods, given that the rules were amended before the expiration of the two-year period, and whether exceptional circumstances existed that would justify an exception to the amended rules. The Applicants also contended that the amended rules, which increased the required period between relocations from two to five years, should not apply retrospectively to their pre-existing plan. The Tribunal was asked to determine if the inability to supply pharmaceutical benefits at the interim premises, due to its scale and location, constituted exceptional circumstances.

Deputy President Constance P reasoned that the Applicants' assumption that the law would not change was not a valid basis for their plan. The Tribunal found that the amendment to the Pharmacy Location Rules in October 2018, which increased the relocation period to five years, was expressly designed to prevent the establishment of temporary pharmacies intended for subsequent relocation. The Tribunal held that the amended rules did not offend the common law presumption against retrospectivity as they had future effect only on future applications and did not alter past events. Furthermore, the Tribunal determined that the Applicants' inability to supply pharmaceutical benefits at the interim premises was a matter of commercial viability, not an inability to supply, and therefore did not constitute exceptional circumstances within the meaning of the rules.

The Tribunal affirmed the Authority's decision of 21 June 2019, which recommended that the Applicants' application for approval to supply pharmaceutical benefits at the proposed new premises not be approved.

Orders

Orders of the court

Background

Background to the litigation

The Applicants have applied to the Tribunal to review the Authority’s decision. For the reasons which follow, the decision will be affirmed.FACTS The relevant facts in this matter are not in dispute and are set out in the statements made by Mr Colasante, the director of the Applicant, Philip Colasante Pharmacies Pty Ltd.[1][1] Statement dated 26 September 2019 (Exhibit A1) and Supplementary Statement dated 11 November 2019 (Exhibit A2). I accept the following evidence of Mr Colasante reproduced from his statement made 26 September 2019: 2. I am the sole director and secretary of Philip Colasante Pharmacies Pty Ltd and I am authorised to make this statement on behalf of the Applicants.…4. I was registered as a pharmacist in January 1996. I acquired my first pharmacy located at Kensington Park [South Australia] in April 1998.5. I commenced a relationship with the pharmacy group known as Chemist Warehouse in August 2000 and have worked within that group since and have acquired and developed pharmacy businesses within that group.6. In about early 2016 Chemist Warehouse and I identified opportunities for the acquisition and development of pharmacy businesses in Salisbury [South Australia].7. I developed a strategic plan for the acquisition of a pharmacy in the Parabanks Shopping Centre for the purpose of relocating its PBS approval to a large site outside the shopping centre whilst being able to obtain a further approval within the Parabanks Shopping Centre.8. After a considerable amount of research Chemist Warehouse group and I identified suitable sites for the operation of a large-scale discount pharmacy in Salisbury. At that time I had also negotiated the prospective purchase of a pharmacy business within the Parabanks Shopping Centre.9. At that time I was aware that the pharmacy location rules would not permit a direct relocation of a PBS approval from Parabanks Shopping Centre to the sites that would suit a large-scale discount pharmacy as rule 124 precluded the relocation to a site within 500m of any existing approved pharmacy not located within the Parabanks Shopping Centre.10. In my estimation the strategic plan developed for acquisition and expansion of pharmacy interests in Salisbury was commercially strong enough to warrant the temporary establishment of an interim pharmacy business for a period of two years as a pre-requisite step to being able to establish the desired large-scale discount business.11. At that time and, to my understanding, for at least twenty years the pharmacy location rules permitted further relocations of approvals pursuant to the short distance rules every two years.12. Accordingly, I identified a site for the temporary location of an approved pharmacy at 1/74 Park Terrace, Salisbury (Interim Premises).13. Once the Interim Premises had been identified agreements were entered as follows:a. Contract for the purchase of Salisbury Chemmart Pharmacy within the Parabanks Shopping Centre for a price of $2,000,000 plus $178,871.98 for stock dated 28 July 2016.b. A Heads of Agreement for a sublease of the Interim Premises dated 1 July 2016.14. On 5 May 2017 the approval for the Parabanks Shopping Centre pharmacy was relocated to the Interim Premises. At the same time I applied for a new approval at the Parabanks Shopping Centre premises, following which an approval was granted.15. At that time the Chemist Warehouse group and I identified suitable premises for the large-scale discount pharmacy at 85A John Street Salisbury (“Proposed premises”). A contract was entered on 26 July 2017 for the purchase of the Proposed Premises for the price of $2,290,000.16. At all relevant times the operation of the Interim Premises was designed to minimise expense. Whilst the pharmacy was operated to serve as many customers as possible, its location and scale were only ever designed to meet PBS requirements for the temporary period of two years as a precondition to being able to establish the large-scale discount pharmacy at the Proposed Premises.17. During the financial year ending June 2018, the business at the Interim Premises dispensed 3,340 PBS items with a net loss (before tax) of $205,588.18. During the financial year ending June 2019, the business at the Interim Premises dispensed 6,411 PBS items with a net loss (before tax) of $240,637.…21. At all relevant times the Interim Premises was established as part of a considered and detailed commercial arrangement for the long-term operation of a pharmacy businesses [sic] in Salisbury with the intention of continuing an existing business within the Parabanks Shopping Centre and establishing a large-scale discount pharmacy at the Proposed Premises.22. The plan involved:a. Acquisition of the pharmacy in the Parabanks Shopping Centre;b. Relocation of the approval to the Interim Premises;c. Simultaneous grant of a new approval at the pharmacy within the Parabanks Shopping Centre;d. Relocation of the approval from the Interim Premises to the Proposed Premises after a period of two years; ande. Closure of the business at the Interim Premises simultaneous with the opening of the large-scale discount pharmacy business at the Proposed Premises.23. In October 2018 the Pharmacy Location Rules were amended with respect to time required before relocations were permitted by way of an increase from two years to five years. To my knowledge this is the first time the requirement has been amended for at least twenty years.24. The October 2018 rule amendments provided for a period of six months for transitional arrangements. I am not aware of the reason why the transition arrangements were limited to six months only.25. Immediately following the expiration of two years from the grant of approval at the Interim Premises, I lodged an application to relocate the approval to the Proposed Premises.26. The operation of the pharmacy business at the Interim Premises for any significant period beyond the budgeted two years is untenable and commercially unviable. The Interim Premises are not suitable to sustain a commercially viable pharmacy business in any event, but particularly in circumstances where costs have been, and continue to be, incurred associated with the Proposed Premises.27. I say that if I had been aware of any prospect of increasing the period required at the Interim Premises none of the arrangements pursued as part of the detailed strategy would have been undertaken or put into action.[2][2] Exhibit A1.

Evidence

Evidence Before The Court

Decision

Reasons for decision

In implementing their plan, the Applicants have assumed that the law would not change. In the circumstances of this matter that was not a valid assumption. Nothing in the Act or Rules provides a basis for the argument that this is a relevant consideration. CONCLUSION The decision under review, being the decision of the Australian Community Pharmacy Authority made 21 June 2019 to recommend that the application of Philip Colasante Pharmacies Pty Ltd and Pharmec Pty Ltd for approval to supply pharmaceutical benefits at particular premises not be approved, will be affirmed.

Ratio Decidendi

Legal Principle Established